Quantbot Technologies LP I Teos Therapeutics, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$10.95 - $14.6 $51,465 - $68,620	4,700 New	4,700 $51,000
Q4 2022 Feb 13, 2023	SELL	$17.77 - $21.6 $17,094 - $20,779	-962 Reduced 21.86%	3,438 $67,000
Q3 2022 Nov 07, 2022	BUY	$18.6 - $27.25 $19,083 - $27,958	1,026 Added 30.41%	4,400 $83,000
Q2 2022 Aug 09, 2022	BUY	$16.57 - $35.1 $55,907 - $118,427	3,374 New	3,374 $69,000

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.